The University of Bristol is a Russell Group University and one of the most prestigious universities in the UK. It is a thriving international community combining excellence in research and innovation with a vibrant entrepreneurial culture. Research is at the heart of the University's mission and accounts for its international reputation. The University organises its academic affairs across six faculties: Engineering, Science, Biomedical Sciences, Health Sciences, Social Sciences and Law, and Arts. In the 2014 UK Research Excellence Framework (REF2014) confirms its position in the top 10 UK research universities, measured by both research output and research impact. Over 33% of the University’s research was judged to be ‘world leading’, and over 80% of publications were judged to be ‘internationally excellent’. The university was placed in the top 5 institutions for research impact in ten areas. In 2009‐10 the University was allocated the 8th highest share of government research funding in the UK. The University participates in hundreds of international collaborations both within and outside of Europe, including 286 projects under the last framework programme, FP7. REF2014 also confirmed the position of the School of Social and Community Medicine (now Population Health Sciences) as a leading centre for research in population health sciences in the UK and internationally. Fifty per cent of our research was rated as 4 (world leading), and 86% as 4 or 3* (world leading or internationally excellent). 100% of our research impact case studies were rated as world-leading, as was 100% of our research environment.
Our main tasks within the project will be to support specific methodological aspects of the proposal across WP1-4 along the HA3 axis. In particular, we will contribute to the measurement of services and resources task in WP2, drawing on our extensive experience in the area of costing methodology research.
Prof. William Hollingworth is Professor of Health Economics, and leads the Health Economics at the University of Bristol (HEB) group. He is deputy director of the MRC Network of Hubs for Trials Methodology Research ConDuCT-II Hub. He has extensive experience of conducting economic evaluations alongside clinical trials, particularly in the areas of diagnostic testing. He has been a co-applicant on numerous successful clinical trial funding bids, and a partner and WP lead on the EU H2020 project ULTRADIAN.
Dr Sian Noble is a Senior Lecturer in Health Economics. She is chair of the MRC Health Economic Resource Use and Costs Working Group, and has extensive experience of economic evaluation alongside clinical trials, particularly in the areas of orthopaedics and urology. She has been a co-applicant on numerous successful clinical trial funding bids.
Dr Joanna Thorn is a Senior Research Associate in Health Economics. She has a master’s degree in Health Economics and Health Policy. Her research focuses on improving the methods by which we collect resource-use data from patients in randomised controlled trials and on improving costing methodology in general. She has been a co-applicant and lead applicant on a number of MRC methodology funding bids, and has experience of working on applied economic evaluations.
Kirsty Garfield is a Research Associate in Health Economics. She has worked on a number of economic evaluations alongside randomised controlled trials, and is currently studying for a PhD in economic evaluation methodology.